Related Experiment Video
Updated: Feb 19, 2026
09:46
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
Published on: January 20, 2023
8.3K
Human Pluripotent Stem Cells to Engineer Blood Vessels.
Xin Yi Chan1, Morgan B Elliott1, Bria Macklin1
1Department of Chemical and Biomolecular Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, 21218, USA.
Advances in Biochemical Engineering/Biotechnology
|November 2, 2017
Summary
Pluripotent stem cells (PSCs) can be differentiated into vascular cells for regenerative medicine. These cells offer potential for disease modeling and engineering vascular grafts to treat cardiovascular diseases.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Pluripotent stem cells (PSCs) represent a significant advancement in regenerative medicine.
- Cardiovascular diseases remain a leading cause of mortality worldwide.
- PSCs offer a unique model for studying and treating cardiovascular conditions.
Purpose of the Study:
- To discuss the differentiation of PSCs into vascular cells.
- To investigate the functional capabilities of these derived vascular cells.
- To explore their application in engineering microvascular beds and vascular grafts for clinical use.
Main Methods:
- Differentiation of human induced PSCs (hiPSCs) from patients.
- Directed differentiation towards endothelial cells (ECs) and perivascular cells.
- Assessment of functional capabilities of derived vascular cells.
- Engineering of microvascular beds and vascular grafts.
Main Results:
- Successful differentiation of hiPSCs into functional vascular cells (ECs and perivascular cells).
- Demonstrated utility of derived cells in disease modeling.
- Potential for constructing microvascular networks and vascular grafts.
Conclusions:
- PSC-derived vascular cells hold promise for advancing cardiovascular disease research and treatment.
- Applications include patient-specific disease modeling and fabrication of vascular grafts.
- This approach supports the development of regenerative therapies for cardiovascular conditions.
